NABL, CAP, ISO
This assay provides additional information on Coronary Heart Disease (CHD) risk in patients known or suspected to be at increased risk based on factors like family history of premature CHD or Stroke, Hypertension, Cigarette smoking, Obesity, Diabetes mellitus, increased levels of LDL and decreased levels of HDL. High levels of Lp(a) increase cardiovascular risk 2-3 fold. Lp(a) behaves like an acute phase protein and should not be measured during periods of active inflammation and for at least 1 month after Myocardial infarction or Stroke.
- No special preparation required
Thyrocare Technologies Limited is India's first and most advanced Totally Automated Laboratory having its strong presence in more than 2000 cities / towns in India and internationally. Thyrocare isRead More
Service was very excellent
Best service. On time delivery if reports. They did what they said.